ResearchMoz

Transparent Conductors in Thin Film and Organic Photovoltaics-2012

NanoMarkets
Published Date » 2012-02-26
No. Of Pages » 98

Transparent Conductors in Thin Film and Organic Photovoltaics – 2012” is the latest report from NanoMarkets in our ongoing coverage of materials and markets in the photovoltaics sector. In this report, NanoMarkets examines the changing opportunities for different kinds of transparent conductors in the TFPV and organic PV industry.

This report considers how transparent conductors will find markets and help create value for suppliers of leading edge PV technologies under the changed circumstances that PV faces today in which government subsidies are under threat and there are huge pressures to reduce TFPV costs to make it competitive with c-Si PV and with other sources of energy in general.  Taking into account the new dynamics of the TFPV and OPV industry, this report identifies where transparent conductor firms can generate business revenues, both from the older segments of the TFPV/OPV industry and from emerging segments, such as BIPV glass.

This report is designed to help transparent conductor suppliers to understand how the overall changes in the PV industry will influence their sales.  It covers the use of transparent conductors in thin-film Si, CIGS, CdTe, OPV, and DSC and includes a discussion of how both established transparent conductor technology and the latest transparent conducting nanomaterials can make money in the PV market.

As with all NanoMarkets reports, this report includes an eight-year forecast of the markets broken out by type of PV technology and type of transparent conductor material.  In addition, the report discusses the strategies of key firms to watch in this important sector. The forecasts are provided in both value and volume terms.
Table of Contents

Executive Summary

E.1 Changes in the Photovoltaics Market for Transparent Conductors Since the Last NanoMarkets Report
E.2 TFPV and the "New" Entrenched TCOs
E.3 Long-Range Prospects for Nanomaterials in Thin-Film and Organic PV TCs
E.4 Why Flexible PV Matters to the TC Market
E.5 BIPV and TCs: A New Opportunity?
E.6 Some Firms To Watch in the TC Space
E.6.1 Suppliers of Alt-TCOs
E.6.2 Suppliers of Non-TCO TCs – Solution Processable Options
E.7 Summary of Eight-Year Forecasts of TCs in PV Applications
 
Chapter One: Background to this Report

1.1 What Has Happened in the TFPV Market Since the Last Report?
1.1.1 Changes in the TFPV Market that Affect TCs
1.1.2 Why Cost is So Important in PV
1.2 Objectives and Scope of this Report
1.3 Methodology
1.4 Plan of this Report
 
Chapter Two: Transparent Conductors used in PV Applications

2.1 ITO vs. the Alternatives – What Makes Sense Where?
2.2 Alternative TCOs – The New Standard in TFPV
2.2.1 CdTe PV
2.2.2 Thin-Film Silicon PV
2.2.3 CIGS PV
2.2.4 OPV and DSC
2.3 Prospects for Conductive Polymers and Nanomaterial-Based TCs in PV Applications
2.3.1 Nanosilver-Based TCs in PV applications
2.3.2 Carbon Nanotubes and Other Carbon Nanomaterials in PV
2.3.3 Conductive Polymers in PV Applications
2.3.4 PV Applications Likely to Adopt Nanomaterial and Other Non-TCO TCs
2.4 Key Points from this Chapter
 
Chapter Three: Eight-year Forecasts of Transparent Conductors in PV Applications
3.1 Forecasting Methodology and Assumptions
3.1.1 Data Sources
3.1.2 Scope of the Forecasts
3.1.3 Pricing Assumptions
3.2 Eight-Year Forecasts of TCs by PV Technology
3.2.1 CdTe PV – Impact of New CdTe PV Firms on the TC Market
3.2.2 Thin-Film Si PV
3.2.3 CIGS PV
3.2.4 OPV
3.2.5 DSC
3.3 Eight-Year Forecasts in Thin-Film and Organic PV Applications by TC Material
3.3.1 ITO
3.3.2 Other TCOs
3.3.3 Nanosilver and Other Metal-Based TCs
3.3.4 Carbon Nanomaterial-Based TCs
3.3.5 Conductive Polymer TCs
3.4 Summary of Eight-Year Forecasts of TCs in PV Applications
3.5 Alternative Scenarios

Abbreviations and Acronyms Used In this Report

About the Author

List of Tables


Exhibit E-1:  Summary of Transparent Conductors in Thin Film and Organic PV Applications by  Material 2012-2019
Exhibit E-2: Summary of Transparent Conductors in Thin Film and Organic PV By Application 2012-2019
Exhibit 2-1: Important Parameters for Transparent Conductors Used for PV Electrodes
Exhibit 2-2: Transparent Conductor Material Types, Typical Characteristics, Advantages, and Disadvantages
Exhibit 2-3: Overview of Selected CNT Material Firms
Exhibit 2-4: Comparison of Agfa and Heraeus PEDOT-Based Transparent Conductive Coatings
Exhibit 2-5: Suitability of Alternative TC Types to Different PV Technologies
Exhibit 3-1: Average TC Prices by Material 2012-2019 ($ per Square Meter)
Exhibit 3-2: Transparent Conductors in CdTe PV Cells
Exhibit 3-3: Transparent Conductors in Thin Film Si PV Cells
Exhibit 3-4: Transparent Conductors in CIGS PV Cells
Exhibit 3-5: Transparent Conductors in OPV Cells
Exhibit 3-6: Transparent Conductors in DSC PV
Exhibit 3-7: ITO in Thin Film and Organic PV By Application 2012-2019
Exhibit 3-8: Other TCOs in Thin Film and Organic PV By Application 2012-2019
Exhibit 3-9: Nanosilver and Other Metal Transparent Conductors in Thin Film and Organic PV By Application 2012-2019
Exhibit 3-10: Carbon Nanomaterial Transparent Conductors in Thin Film and Organic PV By Application 2012-2019
Exhibit 3-11: Conductive Polymer Transparent Conductors in Thin Film and Organic PV By Application 2012-2019
Exhibit 3-12: Summary of Transparent Conductors in Thin Film and Organic PV By Application 2012-2019
Exhibit 3-13: Summary of Transparent Conductors in Thin Film and Organic PV Applications by Material 2012-2019

List of Figures

NA

Upcoming Reports:

Marine-Derived Pharmaceuticals Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast, 2012 - 2018
By - Transparency Market Research
Description Marine derived pharmaceuticals are the drugs and other pharmacological substances which are made from extracting elements present in marine life. Although the concept of marine ethnomedicine dates back to the 18th and 19th century, actual exploratory work on marine pharmacology began in the mid and late 1960s when groups of chemists in the United States, Japan, and Europe began to explore sponges, marine algae, and other forms of marine life for their medicinal properties.  At present there are several marine-derived pharmaceuticals available in the...
Adjuvants Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
Adjuvant oncology treatment comprises of a class of cancer therapeutics which is followed after primary cancer treatment, to minimize the risk of reoccurrence of cancer. The major forms of adjuvant therapy are radiation therapy, chemotherapy, hormone therapy, biological therapy, and targeted therapy. Before deciding the adjuvant therapy to be used, statistical evidence is used by oncologists for the assessment of risk of disease relapse. Increase in prevalence of cancer, growing reimbursement initiatives by governments and insurance companies covering treatment for cancer and...
Lymphoma Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Lymphoma is a kind of blood cancer which occurs when B or T lymphocytes and leukocytes grow abnormally. In addition, it also occurs if these cells survive longer than their normal life cycle. Lymphoma generally occurs in lymph nodes, bone marrow, spleen, blood and other organs which form a part of the lymphatic system. The common symptoms of lymphoma are swelling of lymph nodes, fever, weight loss, night sweets, anorexia, itching, dyspnoea and fatigue. The common tests applied for the diagnosis of lymphoma are immunophenotyping, FISH (Fluorescence in Situ Hybridization) testing and flow...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...